Impact of the 2014 expert panel recommendations for management of high blood pressure on contempo- rary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014;64:2196 203. 56. Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associ- ated with a large-scale hypertension program. JAMA. 2013;310:699 705. 57. Rakotz MK, Ewigman BG, Sarav M, et al. A technology-based quality in- novation to identify undiagnosed hypertension among active primary care patients. Ann Fam Med. 2014;12:352 8. 58. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years: a randomized clinical trial. JAMA. 2016;315:2673 82. 59. Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a mul- ticenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532 46. 60. Cushman WC, Grimm RH, Cutler JA, et al. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:44i 55i. 61. Asayama K, Thijs L, Li Y, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64:935 42. 62. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white- coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193 8. 63. Mancia G, Bombelli M, Brambilla G, et al. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension. 2013;62:168 74. 64. National Clinical Guideline Centre (UK). Hypertension in adults: diagnosis and management. NICE Clinical Guidelines, No. 127. London, UK: Royal College of Physicians (UK); 2011. 